Shares of Thermo Fisher Scientific TMO fell 1.0% in pre-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share increased 145.24% over the past year to $7.21, which beat the estimate of $6.65.
Revenue of $9,906,000,000 rose by 59.00% year over year, which beat the estimate of $9,720,000,000.
Outlook
Thermo Fisher Scientific hasn't issued any earnings guidance for the time being.
Thermo Fisher Scientific hasn't issued any revenue guidance for the time being.
Conference Call Details
Date: Apr 29, 2021
Time: 08:30 AM
Technicals
Company's 52-week high was at $532.57
Company's 52-week low was at $324.35
Price action over last quarter: down 7.24%
Company Profile
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (17%); life science solutions (38%); and lab products and services (38%).
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.